INDSWIFT LABORATORIES
Back to Income Statement
|
INDSWIFT LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹43 Cr | ₹250 Cr | ₹421 Cr | ₹48 Cr | ₹-2.15 Cr |
What is the latest Consolidated Net Profit of INDSWIFT LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹43 Cr |
| Mar2025 | ₹250 Cr |
| Mar2024 | ₹421 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹-2.15 Cr |
How is Consolidated Net Profit of INDSWIFT LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹43 Cr | -82.78 | |
| Mar2025 | ₹250 Cr | -40.50 | |
| Mar2024 | ₹421 Cr | 784.43 | |
| Mar2023 | ₹48 Cr | Positive | |
| Mar2022 | ₹-2.15 Cr | - | |
Compare Consolidated Net Profit of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹3,255.3 Cr | 7.6% | -8.2% | 220.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 7.6% |
-8.2% |
220.3% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses